LAS VEGAS, Oct. 9, 2015 — DigiPath Labs, a subsidiary of DigiPath, Inc. (OTCBB and OTCQB: DIGP), recently successfully completed voluntary proficiency testing of its ability to detect cannabinoids and terpenoids, accurately identifying potency levels of five cannabinoids and 10 terpenoids in unknown samples.
The testing was administered by Absolute Standards, Inc. of Hamden, CT, an independent third-party. “Potency testing is extremely important for patient care,” explains Dr. Cindy Orser, the Chief Science Officer of DigiPath Labs. “The levels of each cannabinoid and terpenoid enable doctors and dispensaries to recommend products and dosages that will help relieve a patient’s symptoms without going overboard. Third party confirmation of our potency testing provides further assurance to our customers as to the quality and reliability of our services.”
Cannabinoids are chemicals found in the cannabis plant that mimic chemicals naturally found in the human body (endocannabinoids). Cannabinoids from medical marijuana bind with the body’s cannabinoid receptors to rebalance the endocannabinoid system and encourage homeostasis. Terpenoids are compounds found in many plants and are often a component of the smell—lavender, pine, cinnamon, rosemary, and basil have distinct terpene profiles. Many terpenoids have medicinal and antibacterial properties.
In addition to potency testing, DigiPath Labs also performs safety testing for contaminants, including foreign matter, heavy metals, microbials, mycotoxins, pesticides, and solvents.
“Patient safety is our top concern. We helped craft the Nevada testing regulations to be the strictest in the country because we believe that standardization is the only way to ensure that patients know exactly what they’re taking,” explains Todd Denkin, CEO of Digipath Labs. “With this successful test, we have demonstrated that the care we put into setting up the lab and establishing standard operating procedures is paying off.”
For more information about DigiPath Labs, go to http://digipathlabs.com/.
About DigiPath, Inc. (OTCQB: DIGP)
DigiPath, Inc., supports the cannabis industry’s best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the nation. DigiPath’s two business units are DigiPath Labs and TNM News Corp.
For more information, go to www.digipath.com.
Information about Forward-Looking Statements
This press release contains “forward-looking statements” that include information relating to future events, and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Media Contact: DigiPath Labs, Inc.
SOURCE DigiPath, Inc.